Attached files
| file | filename |
|---|---|
| EX-32.1 - CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(B) OR 15D-14(B) - Medidata Solutions, Inc. | mdso-12312017xex321.htm |
| EX-32.2 - CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(B) OR 15D-14(B) - Medidata Solutions, Inc. | mdso-12312017xex322.htm |
| EX-31.2 - CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) OR 15D-14(A) - Medidata Solutions, Inc. | mdso-12312017xex312.htm |
| EX-31.1 - CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) OR 15D-14(A) - Medidata Solutions, Inc. | mdso-12312017xex311.htm |
| EX-21.1 - SUBSIDIARIES OF MEDIDATA SOLUTIONS, INC. - Medidata Solutions, Inc. | subsidiariesoftheregistran.htm |
| EX-10.16 - EXHIBIT 10.16 - Medidata Solutions, Inc. | mcaponeseparationagreement.htm |
| 10-K - FORM 10-K - Medidata Solutions, Inc. | a10-k2017.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-218349, 333-211946, 333-198262, 333-192861, 333-188349, 333-181818, and 333-160461 on Form S-8 of our reports dated February 28, 2018, relating to the consolidated financial statements and financial statement schedule of Medidata Solutions, Inc. and subsidiaries (the "Company"), and the effectiveness of the Company's internal control over financial reporting, appearing in this Annual Report on Form 10-K of Medidata Solutions, Inc. for the year ended December 31, 2017.
Deloitte & Touche LLP
New York, New York
February 28, 2018